Neuberger Berman Group LLC Blueprint Medicines Corp Transaction History

Neuberger Berman Group LLC

  • $123 Billion
  • Q3 2024

A detailed history of Neuberger Berman Group LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Neuberger Berman Group LLC holds 63,879 shares of BPMC stock, worth $6.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
63,879
Previous 53,769 18.8%
Holding current value
$6.01 Million
Previous $5.8 Million 1.92%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$84.1 - $120.5 $850,251 - $1.22 Million
10,110 Added 18.8%
63,879 $5.91 Million
Q2 2024

Nov 14, 2024
BUY
$85.18 - $108.78 $209,627 - $267,707
2,461 Added 4.8%
53,769 $5.8 Million
Q2 2024

Aug 13, 2024
BUY
$85.18 - $108.78 $209,627 - $267,707
2,461 Added 4.8%
53,769 $5.8 Million
Q1 2024

Nov 14, 2024
BUY
$73.17 - $99.79 $644,042 - $878,351
8,802 Added 20.71%
51,308 $4.87 Million
Q1 2024

May 13, 2024
BUY
$73.17 - $99.79 $3.75 Million - $5.12 Million
51,308 New
51,308 $4.87 Million
Q4 2023

Nov 14, 2024
SELL
$43.96 - $92.84 $495,121 - $1.05 Million
-11,263 Reduced 20.95%
42,506 $3.92 Million
Q4 2023

Feb 09, 2024
SELL
$43.96 - $92.84 $626,913 - $1.32 Million
-14,261 Reduced 25.12%
42,506 $3.92 Million
Q3 2023

Nov 14, 2023
BUY
$46.9 - $66.0 $17,165 - $24,156
366 Added 0.65%
56,767 $2.85 Million
Q2 2023

Aug 11, 2023
BUY
$42.2 - $66.37 $558,095 - $877,743
13,225 Added 30.63%
56,401 $3.56 Million
Q1 2023

May 12, 2023
BUY
$37.97 - $50.0 $141,855 - $186,800
3,736 Added 9.47%
43,176 $1.94 Million
Q4 2022

Feb 13, 2023
BUY
$41.06 - $66.48 $471,245 - $762,990
11,477 Added 41.04%
39,440 $1.73 Million
Q3 2022

Nov 15, 2022
BUY
$49.93 - $77.7 $1.4 Million - $2.17 Million
27,963 New
27,963 $1.84 Million
Q4 2019

Feb 12, 2020
SELL
$66.73 - $82.59 $834,125 - $1.03 Million
-12,500 Reduced 55.56%
10,000 $801,000
Q3 2019

Nov 13, 2019
SELL
$72.9 - $101.41 $444,690 - $618,601
-6,100 Reduced 21.33%
22,500 $1.65 Million
Q2 2019

Aug 13, 2019
BUY
$73.54 - $97.8 $632,444 - $841,080
8,600 Added 43.0%
28,600 $2.7 Million
Q1 2019

May 13, 2019
BUY
$48.7 - $86.6 $974,000 - $1.73 Million
20,000 New
20,000 $1.6 Million
Q2 2018

Aug 13, 2018
SELL
$60.96 - $101.18 $591,982 - $982,558
-9,711 Closed
0 $0
Q1 2018

May 08, 2018
SELL
$73.28 - $102.95 $21,177 - $29,752
-289 Reduced 2.89%
9,711 $890,000
Q4 2017

Feb 14, 2018
BUY
$62.91 - $88.32 $629,100 - $883,199
10,000
10,000 $754,000

Others Institutions Holding BPMC

# of Institutions
350
Shares Held
60.3M
Call Options Held
2.25M
Put Options Held
1.18M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.62B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email